Universitätsklinikum Heidelberg — Heidelberg

Public research footprint of Universitätsklinikum Heidelberg, compiled from the ClinicalTrials.gov public registry.

471

Registered studies

136

Active

Recruiting now

261

Completed

Stopped or withdrawn

Most-studied conditions

Lung Cancer, Non-squamous, Non-small Cell · Extensive-stage Small Cell Lung Cancer (ES-SCLC) · Diffuse Large B-cell Lymphoma · Acute Lymphoblastic Leukemia

Recently updated registry entries

NCT06935357 — A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin… (Recruiting)
NCT02872987 — GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding… (Recruiting)
NCT06588855 — A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Universitätsklinikum Heidelberg?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.